P. Larsson

发表

Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms

G. Steineck, S. Linder, M. Seddighzadeh, 2002, International journal of cancer.

Allelic deletion fingerprinting of urine cell sediments in bladder cancer.

R. Shipman, P. Larsson, M. Jewett, 2001 .

Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients

G. Steineck, P. Larsson, H. Wijkström, 2010, Scandinavian journal of urology and nephrology.

Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms

K. Hemminki, Rajiv Kumar, G. Steineck, 2007, Acta oncologica.

Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms

K. Hemminki, Rajiv Kumar, G. Steineck, 2007, Scandinavian journal of urology and nephrology.

Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer

J. Adolfsson, K. Hemminki, Rajiv Kumar, 2006, Scandinavian journal of urology and nephrology.

A single‐nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle‐invasive neoplasms of the urinary bladder

J. Adolfsson, K. Hemminki, Rajiv Kumar, 2006, BJU international.

S‐phase fraction in superficial urothelial carcinoma of the bladderA prospective, long‐term, follow‐up study

P. Larsson, U. Norming, B. Tribukait, 2004, Scandinavian journal of urology and nephrology.

Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene

J. Adolfsson, K. Hemminki, Rajiv Kumar, 2003, International journal of cancer.

Low IL-1α Expression in Bladder Cancer Tissue and Survival

G. Steineck, S. Linder, M. Seddighzadeh, 2003 .

A Population-based Study of 538 Patients with Newly Detected Urinary Bladder Neoplasms Followed during 5 Years

J. Adolfsson, P. Wiklund, G. Steineck, 2003, Scandinavian journal of urology and nephrology.

Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.

J. Adolfsson, K. Hemminki, Rajiv Kumar, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma

J. Adolfsson, G. Steineck, J. Hansson, 2001, British Journal of Cancer.

A serologic marker for fetal risk of congenital heart block.

E. Theander, T. Dörner, P. Larsson, 2002, Arthritis and rheumatism.

Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.

G. Roos, R. Stenling, P. Larsson, 1991, The Journal of urology.

Tumor‐cell proliferation and prognosis in renal‐cell carcinoma

G. Roos, R. Stenling, P. Larsson, 1993, International journal of cancer.

Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry.

G. Wilson, G. Roos, R. Stenling, 1994, The Journal of urology.

Allelic Deletion Fingerprinting of Urine Cell Sediments in Bladder Cancer

R. Shipman, P. Larsson, M. Jewett, 2001, Molecular Diagnosis.

Appropriate Restaging Biopsies After Initial Resection or Topical Intravesical Therapy

P. Larsson, M. Jewett, 1997 .

Oral and systemic immunoglobulin G-subclass antibodies to Actinobacillus actinomycetemcomitans leukotoxin.

P. Larsson, E. Lally, N. Taichman, 1999, Oral microbiology and immunology.

p53 mutations in urinary bladder cancer

J. Adolfsson, K. Hemminki, G. Steineck, 2001, British Journal of Cancer.

Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours

K. Hemminki, Rajiv Kumar, G. Steineck, 2005, International journal of cancer.

Bladder Neoplasms--Regions at Chromosome 9 with Putative Tumour Suppressor Genes

Gunnar Steineck, Johan Hansson, Petra Berggren, 2003, Scandinavian journal of urology and nephrology.

Polymorphisms in DNA repair and metabolic genes in bladder cancer.

K. Hemminki, Rajiv Kumar, G. Steineck, 2003, Carcinogenesis.

Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.

P. Larsson, 1994, Scandinavian journal of urology and nephrology. Supplementum.

Antibiotic prophylaxis for prostate biopsy: benefits and costs

P. Larsson, U. Norming, O. Gustafsson, 1999, Prostate Cancer and Prostatic Diseases.

Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours.

K. Hemminki, Rajiv Kumar, G. Steineck, 2006, Cancer letters.

Bladder cancer characteristics in a population based study of newly detected tumours

J. Adolfsson, P. Wiklund, G. Steineck, 2003 .

Cell proliferation in renal cell carcinoma — a comparative study of cell kinetic methods

G. Wilson, G. Roos, R. Stenling, 2004, Urological research.

Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.

G. Roos, R. Stenling, P. Larsson, 1996, Scandinavian journal of urology and nephrology.

Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry.

G. Roos, R. Stenling, P. Larsson, 1994, Scandinavian journal of urology and nephrology.